Literature DB >> 3261123

Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction.

N Tamaki1, Y Yonekura, K Yamashita, M Senda, H Saji, T Hashimoto, T Fudo, H Kambara, C Kawai, T Ban.   

Abstract

Myocardial viability in persistent thallium (TI)-201 defect is a controversial subject. To assess metabolic activity in segments with persistent defect, stress TI-201 tomography and positron emission tomography using nitrogen-13 ammonia and fluorine-18 2-fluoro-deoxyglucose (FDG) were performed in 28 patients with healed myocardial infarction. The segments with TI-201 perfusion defect in electrocardiogram-determined infarcted areas were selected for assessment. Stress perfusion defect was detected in 61 segments by TI-201 tomography. Twenty-two patients (36%) showed transient defects with redistribution (group 1) and 39 showed persistent defects (group 2). Increase in FDG uptake was observed in 95% in group 1. Among group 2 patients, 15 segments (38%) showed an increase in FDG uptake (group 2A) while the remaining 24 (62%) did not have an increased uptake (group 2B). The decrease in nitrogen-13 ammonia perfusion was more severe in group 2B (-23 +/- 7%) than in group 2A (-13 +/- 9%) (p less than 0.005) and group 1 (-10 +/- 4%) (p less than 0.001). In addition, wall motion scores tended to be lower in group 2B (0.21 +/- 0.71), compared with group 2A (0.67 +/- 0.70) (p = 0.05) and group 1 (0.77 +/- 0.60) (p less than 0.01). These data indicate that metabolic viability was observed in approximately 40% of the segments with persistent TI-201 defect. Preservation of regional perfusion and wall motion in these areas was similar to that in areas with transient TI-201 defect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261123     DOI: 10.1016/0002-9149(88)90212-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Usefulness of reinjection image for evaluating viable myocardium in the infarcted zone on exercise thallium-201 SPECT.

Authors:  S Tomiguchi; M Takahashi; O Shimomura; A Kojima; M Hara; Y Koga; K Minoda; H Yasue; K Hayasaki
Journal:  Ann Nucl Med       Date:  1991-11       Impact factor: 2.668

2.  Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

Authors:  Emerson C Perin; James T Willerson; Carl J Pepine; Timothy D Henry; Stephen G Ellis; David X M Zhao; Guilherme V Silva; Dejian Lai; James D Thomas; Marvin W Kronenberg; A Daniel Martin; R David Anderson; Jay H Traverse; Marc S Penn; Saif Anwaruddin; Antonis K Hatzopoulos; Adrian P Gee; Doris A Taylor; Christopher R Cogle; Deirdre Smith; Lynette Westbrook; James Chen; Eileen Handberg; Rachel E Olson; Carrie Geither; Sherry Bowman; Judy Francescon; Sarah Baraniuk; Linda B Piller; Lara M Simpson; Catalin Loghin; David Aguilar; Sara Richman; Claudia Zierold; Judy Bettencourt; Shelly L Sayre; Rachel W Vojvodic; Sonia I Skarlatos; David J Gordon; Ray F Ebert; Minjung Kwak; Lemuel A Moyé; Robert D Simari
Journal:  JAMA       Date:  2012-03-24       Impact factor: 56.272

Review 3.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

4.  Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.

Authors:  Koichi Morita; Chietsugu Katoh; Keiichiro Yoshinaga; Kazuyuki Noriyasu; Megumi Mabuchi; Takahiro Tsukamoto; Hiroyuki Kageyama; Tohru Shiga; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-18       Impact factor: 9.236

5.  Twenty-four-hour quantitative thallium imaging for predicting beneficial revascularization.

Authors:  J Taki; K Nakajima; H Bunko; M Kawasuji; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1994-11

6.  Usefulness of resting thallium-201 delayed imaging for detecting myocardial viability in patients with previous myocardial infarction.

Authors:  T Tsukamoto; K Gotoh; Y Yagi; H Takatsu; Y Terashima; K Nagashima; N Yamamoto; S Hirakawa
Journal:  Ann Nucl Med       Date:  1993-05       Impact factor: 2.668

7.  Identification of asynergic but viable myocardium in patients with chronic coronary artery disease by gated blood pool scintigraphy during isosorbide dinitrate and low-dose dobutamine infusion: comparison with thallium-201 scintigraphy with reinjection.

Authors:  H Matsuo; S Watanabe; Y Nishida; T Matsubara; M Kano; S Tanihata; Y Matsuno; H Oda; Y Kotoo; H Oohashi
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

8.  99mTc-MIBI (RP-30) to define the extent of myocardial ischemia and evaluate ventricular function.

Authors:  M P Larock; R Cantineau; V Legrand; H Kulbertus; P Rigo
Journal:  Eur J Nucl Med       Date:  1990

9.  Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.

Authors:  C Altehoefer; J vom Dahl; U Buell; R Uebis; E Kleinhans; P Hanrath
Journal:  Eur J Nucl Med       Date:  1994-01

10.  ECG-gated thallium-201 myocardial SPECT in patients with old myocardial infarction compared with ECG-gated blood pool SPECT.

Authors:  T Mochizuki; K Murase; Y Fujiwara; T Itoh; M Miyagawa; S Tanada; A Iio; K Hamamoto; W N Tauxe
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.